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Introduction
A variety of disorders have been targeted for gene therapy with adenoviral vectors, including genetic diseases affecting the liver, lung, muscle, coagulation, etc and acquired diseases, such as cancer. Although adenoviral vectors offer multiple advantages for gene therapy, including accommodation of large genetic sequences, growth to high titers, extraordinary avidity for liver, cell transduction regardless of DNA synthesis, and low insertional mutagenesis potential, it became clear early that adenovirally transferred genes were expressed only transiently with inflammation in treated organs. 1 While shortterm expression of therapeutic genes is compatible with applications, much attention has been paid to prolonging adenoviral gene expression for correcting genetic disorders, where indefinite gene expression is desirable.
Many approaches have been used to analyze the nature of the inflammatory response following adenoviral gene therapy. Activation of CD4
+ and CD8 + cytotoxic T lymphocytes (CTL), as well as B cell-mediated responses have been characterized with studies in normal, immunodeficient and genetically mutated animals. [2] [3] [4] [5] The immunological targets include viral envelope proteins with neutralizing antibodies that interfere with repeated administration of the vector, introduced genes, such as ␤-galactosidase (lacZ), with circulating antibodies, as well as viral proteins that lead to CTL responses in the context of major histocompatibility class (MHC) restriction. Involvement of these mechanisms has been substantiated by prolongation of adenoviral gene expression following perturbation of host immune responses. It was surmised that cells expressing adenovirally introduced genes were cleared by activated immunocytes and/or antibodies against specific gene products, the former being most likely, 3 although persistence of adenovirally introduced genes is regulated by additional host cell mechanisms in respect to transgene survival and replication in episomal locations. 6, 7 Although inflammatory cell infiltrates have been shown in organs with adenoviral gene transfer, whether transduced cells are actually lost has not been directly established. With our interest in liver repopulation with transplanted hepatocytes, including for establishing novel therapies, 8 we hypothesized that transplantation of genetically marked hepatocytes following transduction with an adenovirus vector will allow direct analysis of their fate in intact animals. Therefore, we used our recently described systems where normal hepatocytes are transplanted and localized in the liver of dipeptidyl peptidase IV-deficient (DPPIV−) F344 rats. 9 This system offered us opportunities for examining whether adenoviral gene transfer had effects upon the liver of normal hosts, including in respect to future cell engraftment. Changes in the liver of these normal hosts were compared with immunodeficient animals to distinguish between the relative contributions of viral gene expression and host immune responses in respect to the survival of transduced cells.
Results
The viability of transduced primary rat hepatocytes was tested in cell culture after establishing optimal conditions for adenoviral infection. In multiple experiments, 70-100% transduced hepatocytes expressed lacZ in overnight cultures. Trypan blue dye exclusion showed that viability in control nontransduced cells was 95 ± 3% compared with 91 ± 4% after viral infection (P = NS). Cell attachment efficiencies were also similar (approximately 80%). Thiazolyl blue (MTT) utilization assays showed that metabolic activities were similar in control and transduced cells (55 ± 12 versus 62 ± 8 arbitrary units, respectively, P = NS). When transduced hepatocytes were transplanted into the liver of syngeneic rats, lacZ expression was apparent when examined at 6 h after cell transplantation ( Figure 1 ). However, even at this early time after cell transplantation, there was evidence for infiltration with macrophages and phagocytes, indicating activation of a host response.
Transduced cells are cleared rapidly in vivo
In an initial experiment, we examined the fate of transplanted hepatocytes in DPPIV− F344 rats after cell transplantation. Both control and test (adenovirally transduced cells) animals received 1 × 10 7 cells each with three animals constituting each time-point. At 2 h, transplanted cells were distributed in portal areas and hepatic sinusoids, with similar number of cells in both groups b a ( Figure 2 ). However, subsequently, transplanted cells were difficult to demonstrate in recipients of Ad␤gal-infected hepatocytes. At 4 weeks, control animals showed 155 ± 8 transplanted cells, whereas test animals showed only one to two transplanted cells per 100 portal areas (P Ͻ 0.001, t test). The data indicated that the majority of Ad␤gal-transduced cells were cleared from the liver during this time. In further studies, we examined the earliest time at which transduced cells were cleared. These studies showed that as early as at 24 h after transplantation, Ͼ90% of the adenovirally transduced hepatocytes had been cleared from the recipient liver.
Adenovirally transduced cells are cleared repeatedly
To determine further the fate of transplanted cells, we studied two groups of three DPPIV− F344 rats each. These animals received either nontransduced (control) or adenovirally transduced (test) hepatocytes on days 0, 14 and 28. Liver biopsies were obtained on days 7 (after first cell transplantation) and 21 (after second cell transplantation), followed by killing of animals on day 56 for final analysis. The data showed that transduced cells were cleared rapidly each time. For instance, at 7 days, following the first cell transplantation, control animals showed 148 ± 6 transplanted cells, whereas test animals showed only 3 ± 1 transplanted cells per 100 portal areas (P Ͻ 0.001, t test). At the end of the 56-day experiment, the number of transplanted cells in control animals rose to 375 ± 27 cells per 100 portal areas (2.5-fold mean increase) compared with at 7 days after first cell transplantation. However, there were no transplanted cells in the liver of test group animals at 56 days.
In a related experiment, we examined whether previous clearance of adenovirally transduced hepatocytes activated rejection of subsequently transplanted nontransduced hepatocytes. The experimental design was identical to the above study, with the exception that the test group of rats received Ad␤gal-transduced hepatocytes on the first occasion (day 0) only. On days 14 and 28, nontransduced hepatocytes were transplanted in both test and control group animals. Analysis of cell survival showed that the number of transplanted cells rose pro-a b c d
Figure 2 Clearance of transduced hepatocytes in the liver. (a) Transplanted cells in the liver of a control animal at 2 h showing DPPIV-positive hepatocytes (arrow) distributed in sinusoids adjacent to a portal area. (b) Showing distribution and number of adenovirally transduced hepatocytes in the liver of a test animal at 2 h, which were similar to control animals. (c) Liver from a control animal at 4 weeks showing transplanted cells integrated in the parenchyma (arrow). (d) Liver from a representative test animal showing an absence of transplanted cells at 4 weeks after transplantation.
gressively in control animals with 38 ± 8 cells at 7 days, 65 ± 4 cells at 28 days, and 80 ± 11 cells per 100 portal areas at 56 days (P Ͻ 0.01, ANOVA). In test animals, transplanted cell numbers were markedly attenuated at 7 days, similar to previous findings when virally transduced cells were transplanted. On the other hand, at days 28 and 56, there were 33 ± 6 cells and 40 ± 3 cells per 100 portal areas, respectively, in test animals. These findings suggested that nontransduced cells were not rejected in animals that received adenovirally transduced hepatocytes previously, although transplanted cell survival became inferior in this situation.
Adenoviral gene transfer interfered with hepatocyte engraftment and survival
To examine directly whether adenoviral gene expression perturbed the host liver and interfered with transplanted cell survival, we administered 1.4 × 10 8 blue-forming units (b.f.u.) Ad␤gal i.v. to a group of four DPPIV− rats (day 0). One day later, these animals were transplanted with 1 × 10 7 hepatocytes. In a second group of animals, cells were transplanted without prior adenovirus administration. Two animals each from these groups were killed at 7 days and 21 days after initiating the experiment.
Analysis of lacZ expression at 7 days showed that approximately 70-80% hepatocytes stained blue in virus recipients ( Figure 3 ). In control animals, 275 ± 15 transplanted cells were present per 100 portal areas at 7 days and an essentially similar number of cells was found at 21 days (P = NS). In contrast, the number of transplanted cells in adenovirus recipients was less at 7 days (125 ± 5 transplanted cells per 100 portal areas, P Ͻ 0.001, t test), and became further attenuated at 21 days (55 ± 8 cells per 100 portal areas, P Ͻ 0.001, t test). These findings were compatible with impaired transplanted cell engraftment and survival in the setting of adenoviral gene expression and host immune response in the liver.
In another experiment, we transplanted hepatocytes in two DPPIV− rats followed by i.v. injection of 6 × 10 9 b.f.u. adenovirus 2 weeks later. Liver biopsies were obtained from the animals before adenovirus injection. The animals were killed 1 week later to allow adenoviral gene expression and liver examined for evidence of changes in the number of transplanted cells. We expected that in the presence of hepatotoxicity, the number of transplanted cells should have become depleted, provided transplanted cells were infected with the adenovirus. However, we found that while lacZ expression was distributed in host hepatocytes throughout the liver lobule, cells located in the immediate vicinity of portal areas, including transplanted cells, did not express lacZ (Figure 4) . Moreover, the number of transplanted cells increased after adenovirus injection. In biopsies obtained 
Figure 4 Effect of Ad␤gal expression upon host liver. (a) Shows lacZ expression in host hepatocytes (short arrow), along with its absence in transplanted cells (long arrows) situated in periportal areas. (b) Liver biopsy from the same animal as in (a) before Ad␤gal administration showed transplanted cells (arrow) in clusters of one to two cells. (c) Showing a larger cluster of transplanted cells subsequent to Ad␤gal (arrow), indicating the onset of cell proliferation.
before Ad␤gal administration, 325 ± 23 transplanted cells were present per 100 portal areas, whereas this increased to 510 ± 42 per 100 portal areas (P Ͻ 0.01, t test) subsequently. We interpreted these findings to indicate that adenoviral expression was associated with cell death in the liver, which led to proliferation in surviving cells, including transplanted cells, which became reporters in this process.
Evidence for hepatic apoptosis following Ad␤gal infection TUNEL assays showed that apoptosis rates were significantly increased in the Ad␤gal-treated liver ( Figure 5 ). In the normal rat liver, only an occasional cell in two or three lobules (Ͻ0.001%) was positive for apoptosis. In contrast, in rats examined at 7 days after Ad␤gal infection (6 × 10 9 b.f.u.) apoptosis was much greater with 9 ± 3 apoptotic cells per high power field (×400; P Ͻ 0.001, t test). To determine whether apoptosis was due to the effect of adenoviral proteins themselves upon host cells, we injected 1 × 10 8 b.f.u. adenovirus in SCID mice lacking T, B, NK and LAK cells, followed by histological examination of the liver 1 week later. Increased apoptosis, similar to non-immunodeficient rats, was observed with TUNEL assays in these mice. However, there was no evidence for inflammatory cell infiltration in SCID mice at this time, suggesting the possibility of direct hepatocyte toxicity from some viral gene product(s).
Characterization of inflammatory cell infiltrate in animals with cell transplantation
To understand the nature of host immune response, especially at early times after transplantation of Ad␤gal-infected hepatocytes, we analyzed tissues for the presence of activated macrophages, as well as CD4 and CD8 lymphocytes ( Figure 6 ). The studies showed that within a b
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Figure 6 Nature of inflammatory cell infiltration in Ad␤gal-hepatocyte recipients. Immunostaining of liver at 2 h after transplantation of virus infected hepatocytes showing OX-43-positive macrophages (a), CD4-positive lymphocytes (b), and CD8-positive lymphocytes (c) (thin, long arrows). Tissues were reacted for DPPIV activity first and show inflammatory cells within groups of transplanted cells (short arrows).
2 h of cell transplantation, there was infiltration of transplanted hepatocytes with OX-43 positive, as well as CD4-and CD8-positive cells, indicating involvement of these immunocytes in cell clearance.
Discussion
The findings were instructive in several respects concerning adenoviral gene therapy. First, it was established that adenovirally transduced hepatocytes were rapidly cleared in the host liver. Second, we found that the inflammatory response was activated virtually immediately, with significant involvement of activated macrophages and phagocytes additional to CD4 + and CD8 + lymphocytes in the host liver. Finally, we learnt that adenoviral gene expression and consequential host immune response led to significant alterations in the host liver with apoptosis in host hepatocytes, as well as interference in engraftment of transplanted hepatocytes. Taken together, these findings advance our knowledge concerning adenoviral hepatic gene therapy and provide new ways to analyze interactions among viral, cellular and host factors. Losses of adenovirally transduced hepatocytes were compatible with previous studies demonstrating activation of CTL responses in hosts. [2] [3] [4] [5] However, the rapidity with which transduced cells were cleared was remarkable. The rapid kinetics of transduced cell losses was verified in several of our experiments. We found only rare surviving hepatocytes in the liver after the first day following transplantation. Not all transplanted hepatocytes expressed lacZ and thus it is possible that hepatocytes surviving beyond the first days, few as these were, had been nontransduced and did not express either lacZ or viral proteins. In contrast, previous studies found that hepatic gene expression following adenoviral infection in the liver of intact animals persisted for several weeks. 1 In our experience and that of others adenoviral gene expression requires several days, up to 4 days or longer after viral injection into intact animals. 10 On the other hand, when hepatocytes were transduced in vitro, we found that lacZ was expressed within 6 h of viral infection. Although overexpression of non-self transgenes, including lacZ has been documented to induce deleterious host immune responses, it is no longer considered that antibodies directed against transgenes are primarily responsible for the clearance of transduced cells. 3 However, early overexpression of immunogenic viral proteins could activate cell-mediated host responses and our data favored this possibility. We found that cell viability was not perturbed following adenoviral transduction of hepatocytes, which was similar to previous more detailed analysis showing preservation of glucose metabolism, protein synthesis, urea excretion and xenobiotic disposal mechanisms in transduced hepatocytes. 11 Our use of dual labels to demonstrate transgene expression and cell survival excluded confounding by transgene losses. Studies in animals showed that in vivo administration of recombinant adenovirus is associated with the loss of Ͼ90% vector DNA within 24 h. 6 In addition, vector DNA has been found not to undergo replication in transduced cells. 7 A number of adenoviral genes additional to E-1 region genes are known to modulate the host immune response. These include E-2A and E-4 region genes, which contribute toward longer transgene expression, although clearance of vector genome itself from transduced cells is unaltered. [12] [13] [14] While activation of CD4 + and CD8 + cells has been stressed in the clearance of adenovirally transduced cells, we additionally found that OX-43 + activated macrophages, as well as phagocytes were activated within hours following transplantation of adenovirally transduced cells. Studies to prolong expression of adenovirally transferred genes with modulation of CTL responses, such as by depletion of CD4 + T cells, 15, 16 manipulation of CD40 ligand-CD40 interactions, 17 regulation of thymic antigen processing, 18 or perturbation of the CD28/B7 pathway by CTLA4Ig, 19 showed longer gene expression, implying roles for additional mechanisms. The role of E-3 region genes in attenuating host immune responses, as observed in the setting of MHCrestricted allograft rejection, 20 as well as gp19K-mediated sequestration of MHC class I proteins leading to prolongation of adenoviral gene expression are also noteworthy. 21 In addition, insertion of the entire E-3 region in viral vectors is associated with prolongation of gene expression. 22 The implications are that while many adenoviral proteins are deleterious, others may protect the virus against premature clearance from cells. Moreover, MHC haplotype distributions in hosts further alter immune responses against adenoviral vectors.
5 Nonetheless, we found that clearance of adenovirally transduced cells in animals was not associated with unmasking of autoantigens because transplantation of normal hepatocytes in these recipients led to cell engraftment without inflammatory activity in the liver.
The involvement of macrophages and phagocytes in clearing adenovirally transduced cells has not previously been stressed. In this respect, our findings are in agreement with studies showing the benefits of cyclophosphamide in prolonging adenoviral gene expression. 23 Although cyclophosphamide has major effects upon B cells, it also depletes macrophages and injures hepatic endothelial cells. 24 Injury to the hepatic endothelium is likely to perturb the hepatic microenvironment, including the possibility of altered function in resident macrophages, which are potent sites of cytokine release in the liver. We found that adenoviral gene transfer in the liver interfered with subsequent engraftment of transplanted hepatocytes. Moreover, there was evidence for increased apoptosis in the liver subjected to adenoviral gene transfer. Mechanisms leading to apoptosis include perturbations in specific genetic pathways within cells, for example, p53 or Fas overexpression with complementary activities in interacting cells, such as expression of Fas ligand in CTL and activated macrophages. 25 Release of various immunomodulatory cytokines from activated macrophages, including interleukins, interferons, TNF␣, etc, could have further enhanced cytotoxicity and inhibited engraftment of transplanted cells.
Hepatocyte transplantation systems have been of interest for ex vivo gene therapy, as well as for studies of fundamental mechanisms concerning liver growth control, regulation of gene expression and analysis of liver physiology. 8, 30 Use of adenoviral vectors for modifying isolated cells followed by their transplantation into intact animals could facilitate these studies. However, our findings concerning rapid clearance of transplanted cells should alert investigators to the limitations of the adenoviral gene transfer approach. On the other hand, ex vivo systems should be especially useful in dissecting transduced cell and transgene expression-related events from host immune responses for establishing the value of relevant vector modifications.
Materials and methods

Cells
Primary hepatocytes were isolated by in situ collagenase perfusion of the rat liver as described previously. 9 Collagenase was from Boehringer Mannheim, Indianapolis, IN, USA. Cell viability was documented by trypan blue dye exclusion, attachment to tissue culture plastic in RPMI 1640 medium containing penicillin, streptomycin, amphotericin B (GIBCO, Grand Island, NY, USA) and 10% fetal bovine serum (FBS) (Hyclone, Logan, UT, USA), and by measuring conversion of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) to its blue formazan product. 26 After incubating cells with 0.5 mg MTT/ml culture medium for 30 min at 37°C, MTT-containing medium was removed, cells were lysed, the blue formazan product was dissolved in isopropanol for 1 h and optical density was read at 560 nm. IN, USA) . The animals were housed under 14 h light and 10 h dark cycles with standard pelleted rodent diet and water ad libitum. The animals were anesthetized with inhaled ether and used in groups of three to four each. Each rat received 1 × 10 7 hepatocytes via the spleen as described previously. 9 In several animals, wedge liver biopsies were performed for sequential tissue analysis as described previously. 27 Adenovirus suspended in normal saline was injected i. 28 Viral concentration was determined by optical density measurement at 260 nm, with documentation of the viral titer by measuring b.f.u. as described previously. A constant number of HuH−7 cells (1 × 10 5 ) was incubated with serially diluted virus and the number of b.f.u. counted in random areas. To infect hepatocytes, cells suspended in serumfree RPMI 1640 culture medium were incubated for 20 min at 4°C with adenovirus at 20 multiplicity of infection (MOI). After two washes in serum-free culture medium, cells were either transplanted into recipients or cultured for in vitro analysis. LacZ expression was detected in cells after culture for 24 h. Cells were fixed in 0.5% glutaraldehyde in phosphate-buffered saline (PBS), pH 7.4, for 10 min and fixed cells were incubated overnight with 1 mg/ml 5-bromo-4-chloro-3-indoyl-␤-d-galactoside (Xgal) in 5 mm potassium ferricyanide, 5 mm potassium ferrocyanide and 2 mm magnesium chloride.
Animals
Histochemical analysis
Tissues were embedded in OCT resin (Miles, Elkhart, IN, USA) and frozen in methylbutane cooled to −70°C. To localize lacZ activity, 5 m thick cryostat sections were fixed in absolute ethanol, incubated for 16-20 h at 37°C with X-gal and lightly counterstained with eosin and hematoxylin. To localize transplanted cells containing DPPIV activity, cryostat sections were fixed for 10 min in absolute ethanol at 4°C and incubated with the glycyl-lproline-4-methoxy-2-naphthylamide substrate, along with Fast Blue B salt. 9 LacZ activity in transplanted cells was localized in serial sections. To colocalize transplanted cells and lacZ activity, ethanol-fixed tissues were first subjected to DPPIV staining followed by staining with X-gal. The number of transplanted cells in 50-100 consecutive portal areas was counted in tissue sections for morphometric analysis.
To localize activated macrophages, CD4 + lymphocytes and CD8
+ lymphocytes, tissues were reacted with OX-43 monoclonal antibody (Accurate Chemical and Scientific Corporation, Westbury, NY, USA), anti-rat CD4 monoclonal antibody (PharMingen, San Diego, CA, USA), and anti-rat CD8 monoclonal antibody (Caltag, San Francisco, CA, USA), respectively, after staining for DPPIV activity as described above. Immunostaining with the antibodies used blocking with sheep serum diluted 1:20 in PBS for 20 min, followed by three washes in PBS and incubation with the antibodies diluted 1:50 in PBS for 1 h at room temperature. After three rinses in PBS, tissue sections were incubated with a biotinylated supersensitive multilink antibody (BioGenex, San Ramon, CA, USA) for 30 min followed by detection with an avidin-biotin system using the horseradish peroxidase reporter (Vector Laboratories, Burlingame, CA, USA).
DNA synthesis assays
Animals were given 50 mg/kg bromodeoxyuridine (BrdU; Boehringer Mannheim, Indianapolis, IN, USA) i.p. 2 h before being killed. To detect BrdU incorporation, cryostat sections were fixed in cold ethanol and blocked with 2% rabbit serum, followed by incubation for 1 h with anti-BrdU (Amersham Life Sciences, North Chicago, IL, USA). Antibody binding was detected with a supersensitive multilink antibody system using the peroxidase reporter (BioGenex Laboratories, San Ramon, CA, USA) and color development used a Vectastain kit (Vector Laboratories). DNA synthesis in transplanted cells was analyzed by staining for DPPIV activity followed by BrdU immunostaining.
Demonstration of apoptosis
Cryostat tissue sections of 5 m thickness were analyzed with a commercial assay using the peroxidase detection system (Boehringer Mannheim). Tissues were fixed in cold ethanol for 10 min followed by further processing according to the manufacturer's instructions. The assay identifies DNA strand breaks occurring during apoptosis by labeling of free 3′-OH termini with modified nucleotides. The enzymatic reaction utilizes terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick endlabeling (TUNEL assay). 29 
Statistical methods
The data are presented as means ± s.d. The significance of differences was analyzed with the Student's t test or analysis of variance (ANOVA) with SigmaStat 2.0 software (Jandel Scientific, San Rafael, CA, USA). A P Ͻ 0.05 was considered significant.
